ED
Exane Derivatives’s Merck MRK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $5.91M | Sell |
64,879
-3,015
| -4% | -$275K | 3.4% | 3 |
|
|
2022
Q1 | $5.57M | Buy |
67,894
+10,456
| +18% | +$858K | 1.57% | 7 |
|
|
2021
Q4 | $4.4M | Sell |
57,438
-4,987
| -8% | -$382K | 1.07% | 13 |
|
|
2021
Q3 | $4.69M | Buy |
62,425
+8,947
| +17% | +$672K | 1.13% | 11 |
|
|
2021
Q2 | $4.15M | Buy |
53,478
+2,036
| +4% | +$158K | 0.94% | 18 |
|
|
2021
Q1 | $3.97M | Buy |
51,442
+3,806
| +8% | +$293K | 1.13% | 16 |
|
|
2020
Q4 | $3.9M | Sell |
47,636
-27,043
| -36% | -$2.21M | 1.15% | 17 |
|
|
2020
Q3 | $6.19M | Buy |
74,679
+20,551
| +38% | +$1.7M | 1.79% | 9 |
|
|
2020
Q2 | $4.19M | Sell |
54,128
-39,418
| -42% | -$3.05M | 1.12% | 19 |
|
|
2020
Q1 | $7.2M | Buy |
93,546
+38,864
| +71% | +$2.99M | 2.01% | 9 |
|
|
2019
Q4 | $5M | Buy |
54,682
+1,580
| +3% | +$145K | 0.93% | 20 |
|
|
2019
Q3 | $4.47M | Buy |
53,102
+1,202
| +2% | +$101K | 0.8% | 18 |
|
|
2019
Q2 | $4.35M | Sell |
51,900
-3,336
| -6% | -$280K | 0.76% | 21 |
|
|
2019
Q1 | $4.59M | Buy |
55,236
+9,274
| +20% | +$771K | 0.91% | 18 |
|
|
2018
Q4 | $3.51M | Sell |
45,962
-9,345
| -17% | -$714K | 0.63% | 31 |
|
|
2018
Q3 | $3.93M | Buy |
55,307
+45,662
| +473% | +$3.25M | 0.74% | 24 |
|
|
2018
Q2 | $590K | Buy |
+9,645
| New | +$590K | 0.1% | 150 |
|
|
2016
Q3 | – | Sell |
-8,878
| Closed | -$511K | – | 597 |
|
|
2016
Q2 | $511K | Sell |
8,878
-759
| -8% | -$43.7K | 0.08% | 128 |
|
|
2016
Q1 | $510K | Sell |
9,637
-6,257
| -39% | -$331K | 0.07% | 118 |
|
|
2015
Q4 | $839K | Buy |
15,894
+5,462
| +52% | +$288K | 0.12% | 75 |
|
|
2015
Q3 | $515K | Buy |
+10,432
| New | +$515K | 0.07% | 106 |
|
|
2015
Q2 | – | Sell |
-20,153
| Closed | -$1.16M | – | 494 |
|
|
2015
Q1 | $1.16M | Buy |
20,153
+5,877
| +41% | +$338K | 0.13% | 80 |
|
|
2014
Q4 | $811K | Buy |
+14,276
| New | +$811K | 0.11% | 95 |
|